UI Hospitals and Clinics
Multicenter Phase II Study of MK-2206 in Previously Treated Patients with Recurrent and Metastatic Nasopharyngeal Carcinoma
Participants in this research study have been diagnosed with advanced nasopharyngeal cancer. The purpose of this research study is to find out what effects, good and/or bad, an investigational drug called MK-2206 has on the participant and the nasopharyngeal cancer. Approximately 6 people will take part in this study conducted by investigators at the University of Iowa. Study involvement will last for approximately 3 years.
Cindy Robertson, 319-356-2778
We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.